» COVID-19 Information


Manage your account, request prescriptions, set up appointments & more.

Don't have an account
Contact Us
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label

CARRA Registry


Clinical Trial Title

Observational Study for Pediatric Rheumatic Diseases: The CARRA Registry

Trial Status

Open to Enrollment

Start Date

June 9, 2015

Trial Type

Pediatric Rheumatology

Specific Condition

Registry for Pediatric Rheumatic Diseases


Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Eligibility Criteria

Ages Eligible for Study:   2 Years to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children with pediatric rheumatic diseases enrolled from participating CARRA sites.

Inclusion Criteria:

  1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A).
  2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures.
  3. Subject and/or parent/legal guardian can read either English or Spanish.
  4. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.

IRB Number


Principal Investigator Name

Daniel Kingsbury, MD

Contact Name

Kristin Hickey



Contact Fax


Contact E-Mail


Last Updated: Wednesday, January 27, 2021 12:09:11 PM